Innovative Healthcare Solutions AppliedVR offers innovative immersive therapeutics for chronic pain and mental health disorders, providing a unique and effective solution for health systems seeking alternative treatment options.

FDA Approval & Breakthrough Designation AppliedVR's RelieVRx has received Breakthrough Therapy Designation and De Novo authorization by the FDA for chronic lower back pain, enhancing its credibility and market acceptance among healthcare professionals and institutions.

Strategic Partnerships & Collaborations Through partnerships with organizations like Veterans Affairs and collaboration with the VHA, AppliedVR has built a strong network that presents opportunities for expansion into new markets and customer segments.

Recent Product Launches & Expansion The recent launch of RelieVRx prescription therapeutic and the expansion into treating workers' compensation patients showcase AppliedVR's growth trajectory and readiness to cater to diverse healthcare needs.

Acquisition & Financial Stability Being acquired by Akili Interactive and having a healthy funding structure with $36M in funding indicates financial stability and potential for scalability, making AppliedVR an attractive partner for investment opportunities.